Charles River Laboratories CRL Business Segments
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | ||
|---|---|---|---|---|---|---|
| Total Revenue by Business | ||||||
| DSA | $2.41B+0.2% | $2.4B-0.5% | $2.41B-0.6% | $2.43B-0.4% | $2.44B-0.5% | |
| Manufacturing | $778.46M+1.6% | $766.41M+0.2% | $764.96M-0.8% | $771.14M+1.1% | $762.62M-0.9% | |
| RMS | $841.38M-0.6% | $846.08M+0.2% | $844.08M+1.9% | $828.43M+0.8% | $821.54M-0.9% | |
| Total by Business | ||||||
| DSA | $41.02M-20.6% | $51.68M-3.2% | $53.37M-14.9% | $62.71M+24.4% | $50.4M+28.1% | |
| Manufacturing | $15.01M-17.8% | $18.26M+7.4% | $17M-13.9% | $19.74M+32.0% | $14.95M+16.2% | |
| RMS | $34.92M+86.6% | $18.71M-48.0% | $36M+2.4% | $35.14M-7.4% | $37.95M-13.6% | |
| Cost of revenue (excluding amortization of intangible assets) by Business | ||||||
| DSA | $1.7B+0.9% | $1.69B-0.9% | $1.7B-0.1% | $1.7B+0.2% | $1.7B+0.1% | |
| Manufacturing | $434.89M+1.2% | $429.84M-1.4% | $435.95M-0.7% | $439.16M-0.1% | $439.63M-0.2% | |
| RMS | $590.92M+2.5% | $576.25M-2.2% | $589.15M+1.7% | $579.06M0.0% | $578.86M-0.3% | |
| Operating Income (Loss) by Business | ||||||
| DSA | $434.48M+2.3% | $424.56M+5.4% | $402.75M-0.8% | $406.03M-3.7% | $421.62M-4.7% | |
| Manufacturing | -$128.83M+30.1% | -$184.28M-32.4% | -$139.19M-0.2% | -$138.92M-22.1% | -$113.75M-59.2% | |
| SG&A by Business | ||||||
| DSA | $222M-7.4% | $239.77M-6.5% | $256.33M-2.7% | $263.32M+2.2% | $257.53M+3.4% | |
| Manufacturing | $137.78M-3.0% | $142.1M+7.3% | $132.41M-0.1% | $132.59M-1.0% | $133.99M+0.9% | |
| RMS | $78.92M-22.3% | $101.53M-1.9% | $103.55M-1.4% | $105.07M+0.7% | $104.3M-6.0% | |
| Foreign exchange by Business | ||||||
| RMS | $1.69M-88.0% | $14.1M+11.7% | $12.63M-4.6% | $13.23M+7.2% | $12.35M+1,782% | |
| Goodwill, Written off Related to Sale of Business Unit by Business | ||||||
| Manufacturing | $0— | $0— | —— | —— | —— | |
| RMS | $0— | $0— | —— | —— | —— | |
| Capital Expenditures by Business | ||||||
| DSA | $135.95M+2.2% | $132.96M+14.7% | $115.91M+2.6% | $112.97M-0.8% | $113.92M-11.2% | |
| Manufacturing | $30.42M-26.6% | $41.43M-5.7% | $43.95M-7.5% | $47.5M+1.2% | $46.92M+21.9% | |
| RMS | $43.12M+11.0% | $38.84M-6.8% | $41.69M-8.8% | $45.7M-11.0% | $51.38M-19.9% | |
| D&A by Business | ||||||
| DSA | $171.86M-1.2% | $174.03M-2.5% | $178.52M-2.1% | $182.27M-2.7% | $187.42M-1.9% | |
| Manufacturing | $93.99M-33.0% | $140.22M-10.8% | $157.13M-1.8% | $160.05M+28.3% | $124.78M+38.7% | |
| RMS | $75.45M-6.9% | $81.08M-3.7% | $84.17M+4.4% | $80.62M+4.1% | $77.45M+4.9% | |
| Intangible Amortization by Business | ||||||
| DSA | $49.7M-5.4% | $52.55M-4.2% | $54.83M-4.4% | $57.36M-4.2% | $59.89M-4.2% | |
| Manufacturing | $60.65M-42.1% | $104.78M-13.3% | $120.78M-2.1% | $123.32M+40.5% | $87.76M+67.2% | |
| RMS | $18.81M-13.5% | $21.74M-8.1% | $23.66M+0.3% | $23.6M+0.3% | $23.52M+0.1% | |
| Goodwill, impaired, accumulated impairment loss by Business | ||||||
| DSA | $4B0.0% | $4B0.0% | $4B0.0% | $4B0.0% | $4B0.0% | |
| Manufacturing | $1.19B+16.1% | $1.03B— | —— | —— | —— | |
| Total Revenue by Geography | ||||||
| Asia Pacific | $218.56M+6.6% | $205.02M+0.6% | $203.89M+3.4% | $197.24M+2.1% | $193.12M-1.9% | |
| Canada | $485.24M-3.2% | $501.03M+0.8% | $497.11M-2.0% | $507.39M+2.1% | $497.05M+3.1% | |
| Europe | $1.12B+1.3% | $1.1B+1.5% | $1.09B+1.0% | $1.08B+1.0% | $1.07B-1.2% | |
| Other | $57.59M-11.2% | $64.87M-0.5% | $65.2M+17.7% | $55.38M+5.0% | $52.74M-0.2% | |
| U.S. | $2.15B+0.3% | $2.14B-1.4% | $2.17B-1.0% | $2.19B-1.0% | $2.21B-1.1% | |
| Long-Lived Assets by Geography | ||||||
| Asia Pacific | $248.45M-1.5% | $252.26M-1.6% | $256.49M-3.5% | $265.76M-1.7% | $270.45M-2.3% | |
| Canada | $636M+2.2% | $622.2M+2.7% | $605.9M+0.1% | $605.21M+0.4% | $602.58M-0.8% | |
| Europe | $1.82B+1.3% | $1.79B+3.2% | $1.74B+1.2% | $1.72B+2.8% | $1.67B+1.4% | |
| Other | $165.57M+2.8% | $161.04M+3.8% | $155.19M+2.6% | $151.2M+3.2% | $146.5M+1.8% | |
| U.S. | $3.5B-3.2% | $3.61B-0.6% | $3.63B-1.7% | $3.7B-1.5% | $3.75B-1.2% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How does Charles River Laboratories break its business down?
- Charles River Laboratories (CRL) reports total revenue by business across 3 parts — DSA, Manufacturing and RMS. Each is extracted from the segment footnotes and tracked over time.
- Where does Charles River Laboratories's segment data come from?
- Segment breakdowns are pulled from the segment footnotes in Charles River Laboratories's SEC filings (the XBRL dimensional tags), so every line ties back to a reported figure. Switch between quarterly, annual, and TTM, or open any segment for its full history.
